2014
San Francisco (United States)
Series F
Innovaccer is a leading global healthtech company specializing in healthcare data integration, analytics and AI-powered solutions that drive value-based care. Innovaccer is headquartered in San Francisco, California, with major offices in India (Noida, Bengaluru) and Abu Dhabi. The company’s primary markets include the United States, where it serves over 130 prominent healthcare organizations—including six of the top 10 health systems—alongside growing international expansion.
Innovaccer offers a cloud-based healthcare data platform that unifies patient information from multiple sources. Its AI-powered analytics help providers and payers identify care gaps, manage populations, and optimize workflows. The company provides care management tools, physician workflow integrations, patient engagement solutions and seamless interoperability with existing healthcare systems—enabling improved outcomes, efficiency and value-based care delivery.
Subscription Fees: Recurring revenue from healthcare organizations subscribing to the Innovaccer Healthcare Data Activation Platform and its modular analytics tools.
Custom Analytics & Consulting Services: Revenue from bespoke analytics projects, consulting and implementation services for healthcare clients seeking tailored solutions.
Training & Support Services: Fees for onboarding, user training and ongoing technical support to optimize platform usage and client success.
Licensing Fees: Licensing of proprietary algorithms, software modules and data models to healthcare organizations and partners.
Professional Services: Additional revenue from integration, data migration and workflow customization for large-scale deployments.
Healthcare Providers: Hospitals, health systems, physician networks and clinics seeking unified data and analytics for better care coordination and outcomes.
Healthcare Payers: Insurance companies and managed care organizations using Innovaccer for analytics, claims management, and value-based care.
Public Sector & Life Sciences: Government agencies and pharmaceutical companies leveraging the platform for population health and researc.
Healthcare IT Professionals: Teams responsible for technology integration and data management across healthcare enterprises.
Product Innovation: Continual investment in AI, machine learning and new platform modules (e.g., AI medical scribes, prior authorization tools) to address evolving healthcare needs.
Market Expansion: Scaling presence in the US, India and Middle East; targeting large health systems, payers and public health organizations.
Strategic Partnerships: Collaborating with major healthcare providers, technology companies and government agencies to expand reach and capabilities.
Customer Success Focus: Prioritizing client outcomes and satisfaction to drive retention, referrals and long-term growth.
Talent & R&D: Investing in top talent and research to maintain a leadership position in healthcare data analytics and A.
$675 million
9
-, Series F
as of January 9, 2025
$3.45 billion
as of N/A
5.11
as of N/A
WestBridge Capital
and 5 more1492
N/A
-
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
January 9, 2025 | Series F | - | - | - | - | B Capital, Generation Investment Management, M12 , Banner MD Anderson Cancer Center, Kaiser Permanente, Danaher |
December 14, 2021 | Series E | $150.0Million | $3.2Billion | $32.9Million | 93.8x | Schonfeld, B Capital, M12, OMERS Growth Equity, Dragoneer Investment Group, Tiger Global Management, Avidity Partners ,Whale Rock Capital Management, Mubadala, Steadview |
February 19, 2021 | Series D | $105.0Million | $1.3Billion | $19.2Million | 60.4x | Tiger Global Management, Dragoneer Investment Group, M12, OMERS, B Capital ,Steadview, Mubadala |
October 8, 2019 | Series C | $70.0Million | - | $13.5Million | Tiger Global Management, Dragoneer Investment Group, WestBridge Capital, M12 | |
January 16, 2019 | Series B | $10.0Million | - | $9.0Million | M12, WestBridge Capital, Lightspeed India | |
May 9, 2018 | Series B | $25.0Million | - | $6.4Million | WestBridge Capital, M12, Lightspeed India, Agile Equity | |
July 13, 2016 | $15.6Million | - | - | $1.8Million | WestBridge Capital, Pravega Ventures | |
May 13, 2015 | Seed | $3.0Million | - | - | 500 Global, Start Smart Labs | |
January 27, 2015 | Undisclosed | - | - | - | 500 Global |
April 23, 2025
March 12, 2025
November 21, 2024